<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20230413057893N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2023-05-31</date_registration>
      <primary_sponsor>Islamic Azad University</primary_sponsor>
      <public_title>Efficiency of combined treatment of clonazepam mouthwash and vitamin B1 and alphalipoic acid supplements in the treatment of idiopathic burning mouth</public_title>
      <acronym></acronym>
      <scientific_title>Comparison of the effectiveness of clonazepam mouthwash and the combined treatment of clonazepam mouthwash, vitamin B1 and alphalipoic acid supplements on burning of mouth in patients with idiopathic burning mouth</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2023-06-22</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>54</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/69670</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: The randomization method is done using random blocks of size 4. In these random blocks of 4, 2 samples are treated with clonazepam mouthwash alone and 2 samples are treated with clonazepam mouthwash and vitamin B1 and alpha lipoic acid supplements. The randomization process is done by Excel software. The type of treatment that the patient will receive is placed in envelopes numbered from 1 to 54 (according to the number of samples). In this way, from the first 4 patients, 2 patients will be treated with mouthwash alone and 2 patients will be treated with mouthwash and their supplements. This process is done by the statistics consultant and they will not open the envelopes until the treatment process starts, Blinding description: The drug and placebo are divided into the same packages with specific and meaningful codes for the statistical consultant, and the researcher and the patient are not aware of the type of drug in each package.</study_design>
      <phase>3</phase>
      <hc_freetext>Idiopathic burning mouth.</hc_freetext>
      <i_freetext>Intervention 1: Control group: These patients are given mouthwash containing clonazepam 0.5 mg/1 cc and are asked to gargle and spit 5 cc after each meal for 2-4 minutes, 3 times a day for 28 days. Intervention 2: Intervention group: Patients are given and asked for mouthwash containing clonazepam 0.5 mg/1 cc. After each meal, gargle and spit 5 cc of this medicine for 2-4 minutes for 3 times a day. In addition, vitamin B1 tablets (300 mg) twice a day and alpha lipoic acid tablets 200 mg three times a day are prescribed for them to take for 28 days.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
All data is potentially shareable after de-identifying individuals

When:
The access period starts 6 months after the results are published

To whom:
Researchers working in academic and scientific institutions and people who are also engaged in industry

Conditions:
They are allowed to use documents only if they use references.

Where to obtain:
Ali Moghadasi;
09190903027;
Department of Oral and Dental Diseases; Department of Dentistry; Tehran Islamic Azad University

How to obtain:
Submitting the request and clarifying the purpose of the request.
If approved, the information will be provided to the applicant

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Ali Moghadasi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No 4, Shahed Street</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1473685686</zip>
        <telephone>+98 21 4407 4766</telephone>
        <email>am.alimoghadasi@yahoo.com</email>
        <affiliation>Islamic Azad University</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Ali Moghadasi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Unit 4; No 4; Shahed street;  East Payambar;  Ashrafi Esfahani Blvd</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1473685686</zip>
        <telephone>+98 21 4407 4766</telephone>
        <email>am.alimoghadasi@yahoo.com</email>
        <affiliation>Islamic Azad University</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Patients with healthy systemic conditions
Patients who feel oral burning more than 2 hours a day in 50% of the day and night and more than 3 months.</inclusion_criteria>
      <agemin>16 years</agemin>
      <agemax>89 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>The presence of any lesions of the pharynx and nose from a clinical point of view
the use of  chemical drugs
hypersensitivity reactions
physical or chemical factors
complete dental prosthesis
bad oral habits such as teeth grinding
oral mucosa disease such as lichen planus
benign migratory glossitis
bacterial, fungal and viral infections
Dry mouth primary or secondary to salivary gland disorders or after radiation therapy
neurological problems
endocrine disorders
digestive diseases
malnutrition
Pregnancy/lactation
sensitivity to clonazepam</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Drugs</i_code>
      <i_code>Treatment - Drugs</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Control group: These patients are given mouthwash containing clonazepam 0.5 mg/1 cc and are asked to gargle and spit 5 cc after each meal for 2-4 minutes, 3 times a day for 28 days.</i_keyword>
      <i_keyword>Intervention group: Patients are given and asked for mouthwash containing clonazepam 0.5 mg/1 cc. After each meal, gargle and spit 5 cc of this medicine for 2-4 minutes for 3 times a day. In addition, vitamin B1 tablets (300 mg) twice a day and alpha lipoic acid tablets 200 mg three times a day are prescribed for them to take for 28 days.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>The degree of mouth burning. Timepoint: Day zero, fourteen and twenty eight. Method of measurement: visual analogue scaling.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Islamic Azad University</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2023-04-10</approval_date>
        <contact_name>Ethics committee of Department of Dentistry, Tehran Azad University</contact_name>
        <contact_address>No. 9, Nistan 9th, Pasdaran Street Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
